Form 8-K - Current report:
SEC Accession No. 0001641172-25-013479
Filing Date
2025-06-03
Accepted
2025-06-03 17:00:11
Documents
14
Period of Report
2025-06-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37792
2 GRAPHIC form8-k_001.jpg GRAPHIC 11158
  Complete submission text file 0001641172-25-013479.txt   278048

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cycc-20250603.xsd EX-101.SCH 3743
4 XBRL DEFINITION FILE cycc-20250603_def.xml EX-101.DEF 26581
5 XBRL LABEL FILE cycc-20250603_lab.xml EX-101.LAB 36613
6 XBRL PRESENTATION FILE cycc-20250603_pre.xml EX-101.PRE 25205
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5747
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 251020582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)